GEN13h
Next-Gen Cas12a System Enables Precise Single and Multiplexed Gene Editing in Cancer
Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.
Le Lézard6h
Mammoth Biosciences Announces New Results on NanoCas ? the First Efficient Ultracompact Extrahepatic Gene Editor
Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, today announced new ...
‘Much-needed hope’ as CRISPR gene editing therapy recommended for sickle cell disease
Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...
Channel 4 News6h
Sickle cell disease: new treatment raises hopes of cure for sufferers
The Exa-cel gene therapy treatment is at the forefront of medical technology. It takes the person’s DNA and “edits” out the faulty sickle gene. It’s expensive, too. According to the manufacturer, ...
Le Lézard6h
Sharif Sayed Joins Le-Vel as Brand & E-Commerce Performance Director, Bringing Expertise to Elevate Growth and Innovation
Le-Vel is excited to announce the addition of Sharif Sayed to its executive team as the new Brand & E-Commerce Performance ...